Cover Image

Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trialResearch in context

Summary: Background: Previous studies demonstrated that induction chemotherapy (IC) followed by de-escalated chemoradiotherapy adapted to tumor response was effective in treating childhood nasopharyngeal carcinoma (NPC), but the toxicity profile of this treatment strategy, and whether childhood pati...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dong-Hua Luo (Author), Xiao-Yun Li (Author), Shan-Shan Guo (Author), Wan-Ping Guo (Author), Li-Ting Liu (Author), Hao-Yuan Mo (Author), Ling Guo (Author), Xiao-Fei Lv (Author), Li-Zhi Liu (Author), Ji-Bin Li (Author), Qing Liu (Author), Pan Wang (Author), Xue-Song Sun (Author), Sai-Lan Liu (Author), Qiu-Yan Chen (Author), Lin-Quan Tang (Author), Hai-Qiang Mai (Author)
Format:	Book
Published:	Elsevier, 2023-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB-IVA cervical cancer
by: Narayan Rajan, et al.
Published: (2014)

Complete remission in very advanced oral cancer by docetaxel, cisplatin, 5-fluorouracil based induction chemotherapy followed by concurrent chemoradiation
by: Tien-En Chiang, et al.
Published: (2018)

Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer
by: Wujian Zheng, et al.
Published: (2017)

The role of cisplatin alternative regimens with radiotherapy in cervical cancer
by: Yi-Ju Amy Chen, et al.
Published: (2015)

Efficacy and safety of weekly versus triweekly cisplatin treatment concomitant with radiotherapy for locally advanced nasopharyngeal carcinoma: A systematic review and pooled analysis
by: Xin Tian, et al.
Published: (2023)

Gemcitabine Combined with Cisplatin Has a Better Effect in the Treatment of Recurrent/Metastatic Advanced Nasopharyngeal Carcinoma
by: Yang Q, et al.
Published: (2022)

Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid-polymer hybrid nanoparticles
by: Qingxia Fu, et al.
Published: (2020)

Apoptosis, autophagy, ferroptosis, and pyroptosis in cisplatin-induced ototoxicity and protective agents
by: Dingyuan Dai, et al.
Published: (2024)

Outcomes of Adding Induction Chemotherapy to Concurrent Chemotherapy for Nasopharyngeal Carcinoma Patients with Moderate-Risk in the Intensity-Modulated Radiotherapy Era
by: Su Z, et al.
Published: (2020)

Co-delivery of Cisplatin(IV) and Capecitabine as an Effective and Non-toxic Cancer Treatment
by: Xiao Xiao, et al.
Published: (2019)

Radioresistant Nasopharyngeal Carcinoma Cells Exhibited Decreased Cisplatin Sensitivity by Inducing SLC1A6 Expression
by: Wenwen Hao, et al.
Published: (2021)

Cost-effectiveness analysis of camrelizumab plus paclitaxel and carboplatin versus sintilimab plus gemcitabine and cisplatin or carboplatin for the first-line treatment of local advanced or metastatic squamous NSCLC in Chinese mainland
by: Xiaoting Liu, et al.
Published: (2024)

Local Irradiation Modulates the Pharmacokinetics of Metabolites in 5-Fluorouracil-Radiotherapy-Pharmacokinetics Phenomenon
by: Ju-Han Liu, et al.
Published: (2020)

A Patients-Based Statistical Model of Radiotherapy Dose Distribution in Nasopharyngeal Cancer
by: Gang Liu, et al.
Published: (2019)

Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma
by: Rui Li, et al.
Published: (2020)

Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo
by: Benyu Nan, et al.
Published: (2022)

Severe hypertriglyceridemia during treatment with intraperitoneal cisplatin and paclitaxel for advanced stage fallopian tube carcinoma
by: Megan Lander, et al.
Published: (2020)

Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
by: Sherman-Baust Cheryl A, et al.
Published: (2011)

Cisplatin and paclitaxel co-delivered by folate-decorated lipid carriers for the treatment of head and neck cancer
by: Jiying Yang, et al.
Published: (2017)

Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma 
by: Fayette J, et al.
Published: (2015)

Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients
by: Zulfan Zazuli, et al.
Published: (2020)

Cisplatin-Induced Anorexia and Pica Behavior in Rats Enhanced by Chronic Stress Pretreatment
by: Zhijun Guo, et al.
Published: (2022)

Ganoderma spore lipid ameliorates docetaxel, cisplatin, and 5-fluorouracil chemotherapy-induced damage to bone marrow mesenchymal stem cells and hematopoiesis
by: Haohui Lin, et al.
Published: (2024)

TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
by: Yixuan Liu, et al.
Published: (2021)

Identification of solamargine as a cisplatin sensitizer through phenotypical screening in cisplatin-resistant NSCLC organoids
by: Yi Han, et al.
Published: (2022)

Localised Delivery of Cisplatin from Chitosan-Coated Titania Nanotube Array Nanosystems Targeting Nasopharyngeal Carcinoma
by: Wan Nuramiera Faznie Wan Eddis Effendy, et al.
Published: (2023)

Increased Angiogenin Expression Correlates With Radiation Resistance and Predicts Poor Survival for Patients With Nasopharyngeal Carcinoma
by: Shan-Shan Guo, et al.
Published: (2021)

Pharmacological inhibition of SMYD2 protects against cisplatin-induced renal fibrosis and inflammation
by: Min Chen, et al.
Published: (2023)

Comparison of Antiemetic Effects of Ondansetron, Granisetron and Tropisetron in Treatment of Acute Emesis Caused By Cisplatin/Paclitaxel Chemotherapy
by: Taner Turan, et al.
Published: (2016)

FTO Gene Polymorphisms Contribute to the Predisposition and Radiotherapy Efficiency of Nasopharyngeal Carcinoma
by: Xiao F, et al.
Published: (2021)

MMP9 Expression Correlates With Cisplatin Resistance in Small Cell Lung Cancer Patients
by: Longqiu Wu, et al.
Published: (2022)

Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results
by: Candelaria Myrna, et al.
Published: (2006)

Magnesium-Assisted Cisplatin Inhibits Bladder Cancer Cell Survival by Modulating Wnt/β-Catenin Signaling Pathway
by: Tianye Li, et al.
Published: (2022)

Renoprotective effect of isoliquiritigenin on cisplatin-induced acute kidney injury through inhibition of FPR2 in macrophage
by: Tan Rui-zhi, et al.
Published: (2022)

CircNRIP1 Modulates the miR-515-5p/IL-25 Axis to Control 5-Fu and Cisplatin Resistance in Nasopharyngeal Carcinoma
by: Lin J, et al.
Published: (2021)

Acute kidney injury after multiple cycles of cisplatin chemotherapy: A nomogram for risk assessment
by: Xuejing Zhu, et al.
Published: (2023)

Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways
by: Chao-Yue Sun, et al.
Published: (2018)

Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway
by: Wu T, et al.
Published: (2015)

Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation
by: Hyun-Jung Kim, et al.
Published: (2015)

Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients
by: Hu GF, et al.
Published: (2016)